This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

New Survey: Walgreens' Customers Flock To Independent Pharmacies





Walgreens' Exit Shows How Preferred Pharmacy Networks Can Help Community Drugstores, Consumers

WASHINGTON, March 15, 2012 /PRNewswire-USNewswire/ -- According to a national survey of independent pharmacists, Walgreens' exit from key pharmacy networks is benefiting local drugstores and consumers who changed pharmacies. Independent pharmacists say former Walgreens' consumers are more satisfied, switched pharmacies with ease, and still have many choices despite the absence of almost 8,000 Walgreens stores in their networks.

This survey reveals significant upsides to preferred pharmacy networks and comes on the heels of recent Centers for Medicare & Medicaid Services (CMS) research showing that plans with preferred pharmacy networks are now a popular choice among Medicare seniors.

"Since there are now more pharmacies than McDonalds, Burger Kings, Taco Bells, Pizza Huts and Starbucks combined, public and private payers can offer drug benefits that weed out drugstores that overcharge," said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt. "That's good news not only for consumers, but also for local drugstores. According to a survey of independent pharmacists, Walgreens' customers are now flocking to community pharmacies, switching to them with ease, and getting better care than they did at Walgreens. This shows how preferred pharmacy networks help employers, consumers, and drugstores that offer quality care at a reasonable price."

Results from the national survey of independent pharmacy owners are below (and here):

1. Seventy percent of the independent pharmacists with a Walgreens in their area have seen former Walgreens' customers start filling prescriptions at their pharmacy in the last few months. These pharmacists say they have seen former Walgreens' customers start filling prescriptions in their pharmacy by a 70 to 23 percent margin.

2. Three-fifths of the independent pharmacists with a Walgreens in their area say former Walgreens' customers are more satisfied with their new pharmacies. By a 59 to 2 percent margin, independent pharmacists with a Walgreens in their area say former Walgreens' customers are more satisfied with their new pharmacies (13 percent say they are just as satisfied and 25 percent do not know).

3. Independent pharmacists say they have benefited from the Walgreens contract dispute by a two-to-one margin. These pharmacists say independent pharmacies have benefited by a 50 to 24 percent margin, including a 57 to 22 percent margin among independent pharmacists with a Walgreens in their area.

4. Nearly all independent pharmacists say pharmacy customers have adequate access to pharmacies in their area. Independent pharmacists say customers in their area have adequate access to pharmacies by a 98 to 2 percent margin overall, including a 99 to 1 percent margin among pharmacists with a Walgreens in their area.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 216 million Americans.

Follow PCMA on Twitter

SOURCE Pharmaceutical Care Management Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs